| IMN26 |
dapk-1(gk219) I; glt-3(bz34) IV; nuIs5 V. |
C. elegans |
nuIs5 [glr-1::GFP + glr-1::G(alpha)s(Q227L) V + lin-15(+)] V. dapk-1(gk219) decreases neurodegeneration. Reference: Del Rosario J, et al. BMC Neurosci. 2015 Apr 23;16:25. |
| IMN27 |
dapk-1(gk219) I; glt-3(bz34) IV. |
C. elegans |
Reference: Del Rosario J, et al. BMC Neurosci. 2015 Apr 23;16:25. |
| IMN28 |
dapk-1(gk219) I; nuIs5 V. |
C. elegans |
nuIs5 [glr-1::GFP + glr-1::G(alpha)s(Q227L) V + lin-15(+)] V. Reference: Del Rosario J, et al. BMC Neurosci. 2015 Apr 23;16:25. |
| VC432 |
dapk-1(gk219) I. |
C. elegans |
K12C11.4. Superficially wild type. Attribution: This strain was provided by the C. elegans Reverse Genetics Core Facility at the University of British Columbia, which is part of the international C. elegans Gene Knockout Consortium, which should be acknowledged in any publications resulting from its use. Paper_evidence WBPaper00041807 |